PAINREFORM LTD (PRFX) Stock Price, Quote, News and Summary
NASDAQ:PRFX - Nasdaq - IL0011651580 - Common Stock
PRFX Quote and Key Statistics
PAINREFORM LTD
NASDAQ:PRFX (1/21/2025, 8:21:35 PM)
After market: 3.02 +0.03 (+1%)2.99
-0.03 (-0.99%)
PRFX Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -568.81% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
PRFX Performance and Technical Analysis
PRFX Ownership and Analysts
PRFX Latest News and Analysis
PainReform Provides Further Update on Phase 3 Clinical Trial of PRF-110
TEL AVIV, Israel, Dec. 27, 2024 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) (
Why FedEx Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
PainReform Announces Initial Topline Data for PRF-110 Phase 3 Clinical Trial
TEL AVIV, Israel, Nov. 20, 2024 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) (
PainReform Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders’ Equity Requirement
This notification has no immediate effect on the listing or trading of PainReform’s ordinary shares on the Nasdaq Capital Market TEL AVIV, Israel, Nov. ...
About PRFX
Company Profile
PainReform Ltd. is a pharmaceutical company, which focuses on reformulation of established therapeutics. The Company’s main activity is to develop reformulation of established pain therapeutics. PainReform Ltd provides technology, which is dedicated to prolong and enhance efficacy, minimize adverse effects and increase patients convenience as well as faster return of motor function.
Company Info
PAINREFORM LTD
65 Yigal Alon St.
TEL AVIV-YAFO 6745442 IL
CEO: Ilan Hadar
Employees: 6
Company Website: https://painreform.com/
Investor Relations: http://painreform.com/investors
Phone: 97237177051
PRFX Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 72.99 | 704.73B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 27.38 | 359.88B | ||
| JNJ | JOHNSON & JOHNSON | 14.47 | 356.69B | ||
| MRK | MERCK & CO. INC. | 16.17 | 243.45B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 17.84 | 210.75B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.37 | 199.39B | ||
| PFE | PFIZER INC | 10.33 | 150.97B | ||
| SNY | SANOFI-ADR | 12.43 | 129.60B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 48.75 | 115.69B | ||
| ZTS | ZOETIS INC | 29.09 | 75.58B | ||
| GSK | GSK PLC-SPON ADR | 8.26 | 68.92B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 21.83 | 41.53B |